Betamethasone Valerate
規格
2152-44-5CAS番号
218-439-3EC番号
[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoateIUPAC名
C27H37FO6化学式
476.6 g/mol分子量
BETAMETHASONE VALERATE; Betamethasone 17-valerate; 2152-44-5; Valisone; Betaderm; Luxiq; beta-Val; Tokuderm; Betatrex; Dermabet; Valnac; Rinderon V; Bextasol; Stanoval; DTXSID7022673; Bettamousse; Betamethasone (as valerate); 9IFA5XM7R2; Betamethasoni valeras; NSC-755912; DTXCID702673; CHEBI:31277; 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-; Betamethasone 17 Valerate; 17-Valerate, Betamethasone; Flubenisolonvalerate; Valerate, Betamethasone; Audavate; Betesil; Fucibet; Xemacort; Audavate rd; Betnovate rd; RefChem:54532; Betameth val in coal tar; Betamethasone Valerate Foam; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-pentanoate; Betnovate; Bedermin; Celestoderm; Betneval; Dermosol; Dermovaleas; Betamethasone 17a-valerate; MFCD00867446; Ecoval 70; Betamethasone valerate (Betnovate); C27H37FO6; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate; [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate; Betnovateat; Betamethasone-17-valerate; Betnesol-V; Celeston valerate; beta-Methasone 17-valerate; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate; 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate; (2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate; Topagen (Veterinary); Gentocin (Veterinary); Betaval; Fuciderm; Betoid; Celestoderm V; Celestoderm-V; Betnesol V; Celestan V; Celestan-V; Celestane V; NCGC00274064-01; PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,21-DIHYDROXY-16-METHYL-17-((1-OXOPENTYL)OXY)-, (11.BETA.,16.BETA.)-; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]-, (11.beta.,16.beta.)-; EINECS 218-439-3; Rinderon-V (TN); betamethasone-valerate; Luxiq (TN); Topagen (Salt/Mix); Beta-Val (TN); Betatrex (Salt/Mix); Gentocin (Salt/Mix); Betamethason-17-valerat; Betamethason-17-valerate; Betamethasone valerate RS; UNII-9IFA5XM7R2; SCHEMBL7270; CHEMBL1497; Betamethasone 17alpha-valerate; Betamethasone 17-valerate CRS; orb1309553; orb3025856; HY-B0727R; Betamethasone valerate (Standard); MSK2235; GLXC-23436; HY-B0727; Betamethasone valerate (JP18/USP); BETAMETHASONE VALERATE [JAN]; Tox21_302288; BETAMETHASONE VALERATE [USAN]; s1690; BETAMETHASONE VALERATE [VANDF]; AKOS015994704; BETAMETHASONE VALERATE [MART.]; BETAMETHASONE VALERATE [USP-RS]; BETAMETHASONE VALERATE [WHO-DD]; BETAMETHASONE VALERATE [WHO-IP]; CCG-269509; FB18564; KS-1198; NSC 755912; 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate; BETAMETHASONE 17-VALERATE [MI]; Betamethasone valerate [USAN:USP:JAN]; NCGC00178423-08; NCGC00255185-01; ST075178; SY074182; BETAMETHASONE VALERATE [GREEN BOOK]; CAS-2152-44-5; BETAMETHASONE VALERATE [ORANGE BOOK]; BETAMETHASONE VALERATE [EP MONOGRAPH]; BETAMETHASONI VALERAS [WHO-IP LATIN]; CS-0009628; NS00006017; T1163; BETAMETHASONE VALERATE [USP MONOGRAPH]; 9?-Fluoro-16?-methylprednisolone 17-valerate; A12274; D01357; AB01274710-01; AB01274710_02; Betamethasone valerate for system suitability CRS; F801809; Betamethasone Valerate (Betamethasone 17-Valerate); Q6445931; BRD-K34032314-001-02-5; BRD-K34032314-001-04-1; Betamethasone Valerate Working Standard (Secondary Reference Standard); 9-Fluoro-11?,17,21-trihydroxy-16?-meth ylpregna-1,4-diene-3,20-dione 17-valerate; (11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate; (11?,16?)-9-Fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]pregna-1,4-diene-3,20-dione; (11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate; (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate; 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate; 9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate #; Betamethason 17-valarate別名
Betamethasone Valerateを含む製品
1/10ページ
Betamethasone Valerateを販売する企業
CT
Công ty TNHH Phil Inter PharmaViet Nam한미
한미약품(주)Republic of Korea(주
(주)동구바이오제약Republic of Korea(주
(주)유한양행Republic of Korea(주
(주)테라젠이텍스Republic of KoreaCT
Công ty cổ phần dược MedipharcoViet Nam신풍
신풍제약(주)Republic of Korea(주
(주)에이프로젠바이오로직스Republic of Korea일양
일양약품(주)Republic of Korea1/10ページ